Literature DB >> 26034346

Surgical recurrence in Crohn's disease: Are we getting better?

Ivan Kristo1, Anton Stift1, Michael Bergmann1, Stefan Riss1.   

Abstract

Crohn's disease (CD) still remains a challenging chronic inflammatory disorder, both for colorectal surgeons and gastroenterologists. The need for recurrent surgery following primary intestinal resection is still considerable, though recent evidence suggested a declining rate of recurrence. Several conflicting surgical parameters have been identified that might impact on the postoperative outcome positively, such as access to the abdomen, anastomotic configuration or type of disease. Additionally, promising results have been achieved with the increased use of immunosuppressive medications in CD. Consequently, the question arises if we are getting better as a result of novel medical and surgical strategies.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; Recurrence; Surgical recurrence

Mesh:

Year:  2015        PMID: 26034346      PMCID: PMC4445088          DOI: 10.3748/wjg.v21.i20.6097

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease.

Authors:  M Muñoz-Juárez; T Yamamoto; B G Wolff; M R Keighley
Journal:  Dis Colon Rectum       Date:  2001-01       Impact factor: 4.585

Review 2.  Surgery for luminal Crohn's disease.

Authors:  Takayuki Yamamoto; Toshiaki Watanabe
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

Authors:  P Rutgeerts; G D'Haens; S Targan; E Vasiliauskas; S B Hanauer; D H Present; L Mayer; R A Van Hogezand; T Braakman; K L DeWoody; T F Schaible; S J Van Deventer
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

Authors:  A J Greenstein; P Lachman; D B Sachar; J Springhorn; T Heimann; H D Janowitz; A H Aufses
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

5.  Laparoscopic versus open bowel resection for Crohn's disease.

Authors:  J Tabet; D Hong; C W Kim; J Wong; R Goodacre; M Anvari
Journal:  Can J Gastroenterol       Date:  2001-04       Impact factor: 3.522

6.  The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.

Authors:  Pavol Papay; Walter Reinisch; Elien Ho; Cornelia Gratzer; Donata Lissner; Harald Herkner; Stefan Riss; Clemens Dejaco; Wolfgang Miehsler; Harald Vogelsang; Gottfried Novacek
Journal:  Am J Gastroenterol       Date:  2009-12-15       Impact factor: 10.864

7.  Surgery for inflammatory bowel disease in the era of laparoscopy.

Authors:  Giuseppe S Sica; Livia Biancone
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

8.  A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease.

Authors:  Constantinos Simillis; Sanjay Purkayastha; Takayuki Yamamoto; Scott A Strong; Ara W Darzi; Paris P Tekkis
Journal:  Dis Colon Rectum       Date:  2007-10       Impact factor: 4.585

9.  Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn's disease: who is at risk?

Authors:  S Riss; C Bittermann; S Zandl; I Kristo; A Stift; P Papay; H Vogelsang; M Mittlböck; F Herbst
Journal:  Colorectal Dis       Date:  2010-10       Impact factor: 3.788

10.  Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.

Authors:  Mark Lazarev; Thomas Ullman; Wolfgang H Schraut; Kevin E Kip; Melissa Saul; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

View more
  8 in total

1.  Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease.

Authors:  Ivan Kristo; Stefan Riss; Stanislaus Argeny; Svenja Maschke; Praminthra Chitsabesan; Anton Stift
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

2.  Systems Pharmacological Approach of Pulsatillae Radix on Treating Crohn's Disease.

Authors:  Su Yeon Suh; Won G An
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-01       Impact factor: 2.629

3.  Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn's disease.

Authors:  Stanislaus Argeny; Anton Stift; Michael Bergmann; Martina Mittlböck; Svenja Maschke; Yushan Yang; Praminthra Chitsabesan; Stefan Riss
Journal:  Wien Klin Wochenschr       Date:  2018-02-12       Impact factor: 1.704

4.  Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's Disease.

Authors:  Sung Bae Kim; Jae Hee Cheon; Jae Jun Park; Eun Soo Kim; Seong Woo Jeon; Sung-Ae Jung; Dong Il Park; Chang Kyun Lee; Jong Pil Im; You Sun Kim; Hyun Soo Kim; Jun Lee; Chang Soo Eun; Jeong Mi Lee; Byung Ik Jang; Geom Seog Seo
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

5.  Short-term and long-term outcomes of laparoscopic vs open ileocolic resection in patients with Crohn's disease: Propensity-score matching analysis.

Authors:  Shin Jeong Pak; Young Il Kim; Yong Sik Yoon; Jong Lyul Lee; Jung Bok Lee; Chang Sik Yu
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742

6.  Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review.

Authors:  Huiqin Hu; Xinying Wang; Side Liu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Minimal-invasive approach for penetrating Crohn's disease is not associated with increased complications.

Authors:  Ivan Kristo; Anton Stift; Stanislaus Argeny; Martina Mittlböck; Stefan Riss
Journal:  Surg Endosc       Date:  2016-06-22       Impact factor: 4.584

8.  The modified Glasgow prognostic score in Crohn's disease-does it predict short-term outcome?

Authors:  Stanislaus Argeny; Anton Stift; Michael Bergmann; Martina Mittlböck; Svenja Maschke; Stefan Riss
Journal:  Eur Surg       Date:  2018-03-22       Impact factor: 0.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.